Full Fed. Circ. Won't Review Becton's Wins On Drug Dosing IP
The full Federal Circuit on Monday denied a petition from Baxter Corp. Englewood for review of a panel decision affirming Patent Trial and Appeal Board rulings that invalidated two of the...To view the full article, register now.
Already a subscriber? Click here to view full article